↓ Skip to main content

PI3K/AKT Signal Pathway: A Target of Natural Products in the Prevention and Treatment of Alzheimer’s Disease and Parkinson’s Disease

Overview of attention for article published in Frontiers in Pharmacology, April 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news
2 news outlets
twitter
1 X user

Readers on

mendeley
208 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
PI3K/AKT Signal Pathway: A Target of Natural Products in the Prevention and Treatment of Alzheimer’s Disease and Parkinson’s Disease
Published in
Frontiers in Pharmacology, April 2021
DOI 10.3389/fphar.2021.648636
Pubmed ID
Authors

Hui-Zhi Long, Yan Cheng, Zi-Wei Zhou, Hong-Yu Luo, Dan-Dan Wen, Li-Chen Gao

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 208 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 208 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 19 9%
Student > Bachelor 19 9%
Student > Ph. D. Student 17 8%
Student > Master 15 7%
Student > Doctoral Student 9 4%
Other 26 13%
Unknown 103 50%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 21 10%
Pharmacology, Toxicology and Pharmaceutical Science 18 9%
Neuroscience 13 6%
Agricultural and Biological Sciences 11 5%
Medicine and Dentistry 11 5%
Other 23 11%
Unknown 111 53%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 17. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 November 2022.
All research outputs
#1,907,237
of 23,189,371 outputs
Outputs from Frontiers in Pharmacology
#704
of 16,600 outputs
Outputs of similar age
#51,921
of 434,333 outputs
Outputs of similar age from Frontiers in Pharmacology
#56
of 847 outputs
Altmetric has tracked 23,189,371 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 16,600 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 434,333 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 847 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.